相似文献
1
Glutathione S-transferases (GSTs) polymorphism and taxane (docetaxel) sensitivity in breast cancer.
Transl Cancer Res. 2019 Aug;8(4):1016-1018. doi: 10.21037/tcr.2019.06.42.
2
Glutathione S-transferases and their implications in the lung diseases asthma and chronic obstructive pulmonary disease: Early life susceptibility?
Redox Biol. 2021 Jul;43:101995. doi: 10.1016/j.redox.2021.101995. Epub 2021 May 2.
3
Glutathione S-transferases--a review.
Curr Med Chem. 1999 Apr;6(4):279-309.
4
Human glutathione S-transferases.
Semin Liver Dis. 1998;18(4):345-58. doi: 10.1055/s-2007-1007169.
5
Glutathione S-transferase P1 c.313A > G polymorphism could be useful in the prediction of doxorubicin response in breast cancer patients.
Ann Oncol. 2012 Jul;23(7):1750-6. doi: 10.1093/annonc/mdr483. Epub 2011 Nov 2.
6
Susceptibility of Dermanyssus gallinae from China to acaricides and functional analysis of glutathione S-transferases associated with beta-cypermethrin resistance.
Pestic Biochem Physiol. 2021 Jan;171:104724. doi: 10.1016/j.pestbp.2020.104724. Epub 2020 Oct 17.
7
Assembly of ligands interaction models for glutathione-S-transferases from Plasmodium falciparum, human and mouse using enzyme kinetics and molecular docking.
Comput Biol Chem. 2016 Oct;64:237-249. doi: 10.1016/j.compbiolchem.2016.07.007. Epub 2016 Jul 25.
8
Proposed reductive metabolism of artemisinin by glutathione transferases in vitro.
Free Radic Res. 2001 Oct;35(4):427-34. doi: 10.1080/10715760100300941.
9
Plant glutathione S-transferases: enzymes with multiple functions in sickness and in health.
Trends Plant Sci. 2000 May;5(5):193-8. doi: 10.1016/s1360-1385(00)01601-0.
10
Diversity of Glutathione S-Transferases (GSTs) in Cyanobacteria with Reference to Their Structures, Substrate Recognition and Catalytic Functions.
Microorganisms. 2020 May 11;8(5):712. doi: 10.3390/microorganisms8050712.
本文引用的文献
1
Oncotype DX Recurrence Score as a Predictor of Response to Neoadjuvant Chemotherapy.
Ann Surg Oncol. 2019 Feb;26(2):366-371. doi: 10.1245/s10434-018-07107-8. Epub 2018 Dec 12.
2
Validation of the 21-gene test as a predictor of clinical response to neoadjuvant hormonal therapy for ER+, HER2-negative breast cancer: the TransNEOS study.
Breast Cancer Res Treat. 2019 Jan;173(1):123-133. doi: 10.1007/s10549-018-4964-y. Epub 2018 Sep 21.
3
Breast Cancer Cell Line Classification and Its Relevance with Breast Tumor Subtyping.
J Cancer. 2017 Sep 12;8(16):3131-3141. doi: 10.7150/jca.18457. eCollection 2017.
4
Using the 21-gene assay from core needle biopsies to choose neoadjuvant therapy for breast cancer: A multicenter trial.
J Surg Oncol. 2017 Jun;115(8):917-923. doi: 10.1002/jso.24610. Epub 2017 Apr 13.
5
GSTP1, GSTM1, and GSTT1 polymorphisms as predictors of response to chemotherapy in patients with breast cancer: a meta-analysis.
Cancer Chemother Pharmacol. 2016 Dec;78(6):1163-1173. doi: 10.1007/s00280-016-3173-9. Epub 2016 Oct 26.
6
Predictive role of GSTs on the prognosis of breast cancer patients with neoadjuvant chemotherapy.
Asian Pac J Cancer Prev. 2012;13(10):5019-22. doi: 10.7314/apjcp.2012.13.10.5019.
7
Meta-analysis of the association of breast cancer subtype and pathologic complete response to neoadjuvant chemotherapy.
Eur J Cancer. 2012 Dec;48(18):3342-54. doi: 10.1016/j.ejca.2012.05.023. Epub 2012 Jul 3.
8
Tailoring neoadjuvant chemotherapy for locally advanced breast cancer: a historical prospective study.
Chemotherapy. 2012;58(2):95-101. doi: 10.1159/000336257. Epub 2012 Feb 29.
9
Glutathione S-transferase P1 c.313A > G polymorphism could be useful in the prediction of doxorubicin response in breast cancer patients.
Ann Oncol. 2012 Jul;23(7):1750-6. doi: 10.1093/annonc/mdr483. Epub 2011 Nov 2.
10
Polymorphisms of glutathione S-transferase mu 1, theta 1, and pi 1 genes and prognosis in Hodgkin lymphoma.
Leuk Lymphoma. 2010 Dec;51(12):2215-21. doi: 10.3109/10428194.2010.527402. Epub 2010 Oct 26.
Zotero 插件